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This paper is addressed to two questions: (1) Is there evidence for In- 
creasing hemolysis in patients with a cloth-covered aortic valve pros- 
thesis? (2) Is it possible to predict from the hematocrlt, retrtcutocyte 
count, serum hemoglobin and serum lactic dehydrogenase (LDH) lev- 
els which patients are at risk of anemia? These screening studies were 
performed in patients attending the postoperative clinic from 1979 to 
1973. Patients were classified into anemic and nonanemic groups. LDH 
values for the anemic group include al! yearly values for that patient ln- 
eluding preanemia levels. The median LDH levels showed a yearly ln- 
crease in the anemic group and no change in the nonanemic group (P 
<O.OOS). A subset of these patients had a mean 1 year increase of 3 
LDH units for 15 nonanemic patients and 242 units in 17 anemic pa- 
tients. The reticulocyte levels did not demonstrate any progresstve ln- 
crease in the anemic group. The LDH level was the most useful pridlc- 
tor of future anemia. A value of 250 units predicted anemia on ttie next 
yearly visit with 28 percent false positive and 4 percent false negative 
readings. The reticulocyte count of more than 2.5 percent also placed 
the patient at greater risk of anemia. A serum hemoglobin level In ex- 
cess of 40 mg/lOO ml was common in the anemic patients and was 
present in only 3 of 17 nonanemic patients. It Is suggested that the 
serum LDH level should be monitored in all patients wtth the aortlc to- 
tally cloth-covered prosthesis. Values in excess of 250 unlts (four 
times the upper limit of normal by other LDH methods) or increasing 
levels, or both, suggest future anemia. 
Hemolytic anemia after aortic valve replacement with the totally 
cloth-covered aortic prosthesis has been well documented.1-3 We 
found an initial incidence of 22 percent of severe hemolytic anemia in 
patients with the totally cloth-covered aortic prosthesis.4 Because the 
anemia developed several years postoperatively in some of these pa- 
tients we reviewed our data on patients with hemolysis after valve re- 
placement with this aortic prosthesis in an attempt to answer the fol- 
lowing questions: (1) Is there evidence for increasing hemolysis in pa- 
tients with the cloth-covered aortic valve prosthesis? (2) Is it possible 
to predict in which patients anemia will develop from the hemolysis? 
Methods 
Since late 1970 we have been screening all patients with an aortic valve 
prosthesis for hemolysis. Patients were studied if they were at least 3 months 
postoperative and had no evidence of hepatitis. Laboratory examinations 
consisted of determinations of (I) hemoglobin and hematocrit, (2) reticulo- 
cyte count, (3) serum lactic dehydrogenase (LDH) (normal values 23 to 65 
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TABLE I TABLE II 
Median LDH Values (units) for Each Postoperative Year LDH Activity (units) in Patients with Proved Cloth Wear by 
Postoperative Year 
Year 
Group 1 2 3 4 
Case no. 1 2 3 4 
Anemic 383 (16) 478 (19) 560 (12) 
Nonanemic 181 (20) 150 (18) 187 (11) 
Figures in parentheses indicate sample size. 
653 (11) 
147 (5) 
units),5 (4) serum glutamic oxaloacetic transaminase, (5) 
serum haptoglobin concentration by electrophoresis and, 
since 1972, (6) serum hemoglobin and serum iron levels. 
The blood specimens were drawn in the hospital’s central 
laboratory and were promptly processed. 
1 434 622 870 653 (0~) 
2 320 . . . . . . 2039 (op) 
3 . . . 265 1490 (OP) 
4 670 795 (OP) 
5 * . . . . . . . . 1300 (op) 
op = reoperation (replacement with another aortic valve 
prosthesis); . . . = no values available. 
The criterion for a diagnosis of a significant hemolytic 
anemia secondary to an aortic prosthetic valve was a re- 
duction in hematocrit of 10 volume percent from the pre- 
operative value. Mechanical hemolysis was confirmed by 
finding an increase in reticvlocyte count, an increase in 
LDH levels with electrophoresis of the LPH enzymes dem- 
onstrating the increase to be due to .the fast fractions, nega- 
tive Coombs’ test, elevation of the serum hemoglobin level 
above 5 mg/lOO ml, a decrease in the serum iron concentra- 
fion in the presence of a normal serum iron-binding capaci- 
ty and, most importantly, evidence of red cell fragmenta- 
tion on examination of peripheral film. 
ticulocyte counts, serum LDH and serum hemoglobin lev- 
els for each postoperative year. Values obtained before the 
diagnosis of anemia are included in the appropriate postop- 
erative year under the anemic group. Jonckheere’s nonpar- 
ametric test6 was used to evaluate these results for evi- 
dence of increasing hemolysis in the anemic group in com- 
parison with the nonanemic group. A subgroup of patients 
whose yearly sequential LDH levels were available were 
then compared with the anemic and nonanemic groups to 
again evaluate for increasing hemolysis. Preanemic hema- 
tocrit values, reticulocyte counts and LDH levels were then 
evaluated for their ability to predict future anemia. 
Only patients with a cloth-covered Starr-Edwards aortic 
valve prosthesis, series 2300, 2310 and 2320, were included 
in this analysis. Patients with multiple prosthetic valves, 
one of which was in the aortic position, and patients with 
paravalvular leakage were included in this study. In all pa- 
tients whose diagnosis predated our study, a retrospective 
chart review was carried out to determine the onset of the 
anemia. Paravalvular leakage was considered present if 
there was a left sternal diastolic murmur. Definite leakage 
was considered present if it was at least grade 2/6. 
Anemic and nonanemic groups: Patients with a diag- 
nosis of significant hemolytic anemia as of June 1973 com- 
prised the “anemic” group, and the remaining patients the 
“nonanemic” group. The two groups were compared for re- 
Serum LDH values: The yearly median LDH 
values for the two groups of patients are given in 
Table I. Medians rather than means are reported be- 
cause the LDH values have skewed distributions, 
particularly in the anemic group. The difference be- 
tween values in the anemic and nonanemic groups is 
statistically significant (P <O.Ol) by the rank sum 
test. Figure 1 shows the median LDH values for the 
anemic and nonanemic groups and for all patients by 
postoperative year. 
With these results in mind, Jonckheere’s nonpar- 
ametric test6 for ordered alternates was employed to 
determine whether LDH remained unchanged, indi- 
cating a constant rate of hemolysis, or whether LDH 
levels rose, indicating an increase in hemolysis with 
time. The calculated data in the nonanemic group 
suggest a constant rate of hemolysis and the data in 
the anemic group indicate an increasing rate of he- 
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FIGURE 1. Median LDH levels for all patients and for the anemic 
and nonanemic groups by postoperative (POST-OP) year. Bars indi- 




Patients with proved cloth wear at reoperation 
often show a marked increase in LDH activity (Table 
II). If these patients were deleted from the anemic 
group and the nonparametric test employed, it is evi- 
dent that the LDH levels would still tend to increase 
with time (P CO.05). 
LDH value comparisons over a 1 year interval indi- 
cated that the nonanemic group (15 patients) had a 
mean increase of 3 units of LDH activity and the ane- 
mic group (17 patients) a mean increase of 242 units. 
The greatest change in LDH activity in the nonane- 
mic group was 67 units, whereas 8 of 17 patients in 
the anemic group had an increase of more than 70 
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TABLE III TABLE IV 
Reticulocyte Counts (%) for Each Postoperative Year* 
Year 
Group 1 2 3 4 5 
Anemic 4.8 (18) 6.1 (17) 6.1 (17) 9.2 (12) 4.7 (6) 
Nonanemic 2.2 (28) 2.4 (12) 2.6 (14) 1.8 (7) 3.4 (4) 
* Differences between groups are significant for the first 4 
years (P < 0.01, t test). 
Figures in parentheses indicate sample size. 





Group 1 2 3 4 
Anemic 65 (7) 50 (7) 73 (8) 54 (10) 
Nonanemic 10 (4) 24 (7) 25 (8) 5 (1) 
* Differences between groups are significant only in the 3rd 
year (P < 0.01, rank sum test). 
Figures in parentheses indicate sample size. 
units. However, since 5 of the 17 anemic patients had 
a decrease in LDH activity over a year, it is evident 
that false negative responses occur. 
Reticulocyte count and serum hemoglobin: The 
reticulocyte counts (percent) were less skewed and 
therefore mean values for each postoperative year are 
shown for the two groups in Table III and Figure 2. 
The anemic group had significantly higher reticulo- 
cyte counts for each year (P CO.01 by t test). The re- 
ticulocyte data do not support evidence for increas- 
ing hemolysis in either group by the nonparametric 
test. The serum hemoglobin data are limited because 
this determination was part of the routine screening 
studies for only 1 year; therefore, most of the values 
were obtained at the time of the evaluation for ane- 
mia. Table IV gives the mean serum hemoglobin 
values available. As expected, patients in the anemic 
group had higher values that were significantly dif- 
ferent only in the 3rd year (P CO.01, rank sum test). 
These data cannot be used to evaluate increasing he- 
molysis. 
Hematocrit: The p’redictive ability of sequential 
hematocrit values in the diagnosis of anemia was lim- 
ited. Figure 3 gives sequential hematocrit levels be- 
fore the diagnosis of anemia. In several patients the 
postoperative hematocrit values were lower than pre- 
operative values. However, the hematocrit values in 
some cases dropped rapidly to anemic levels or stabi- 
lized for several years before anemia developed. 
Predictive Value of Reticulocyte Count and Serum 
Hemoglobin 
Using a screening rule of a reticulocyte count of 2.5 
percent or greater to predict anemia within 1 year, 
based on a sample size of 10 preanemic values and 28 
values in patients in whom anemia did not develop, 
one might expect a 10 percent false negative rate and 
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FIGURE 2. Mean reticulocyte counts (percent) for the anemic and 
nonanemic groups by postoperative year. Bars indicate approximate 
90 percent confidence limits for the true group means. 
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FIGURE 3. Sequential hematocrit values, by postoperative year, in 
patients who manifested anemia. 
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values for serum hemoglobin levels were not available 
to establish a predictive rule. However, 17 of 24 ane- 
mic patients had serum hemoglobin values in excess 
of 40 mg/lOO ml, whereas only 3 of 17 nonanemic pa- 
tients had values greater than 40 mg/lOO ml. 
Predictive value of LDH levels: Estimated 
probabilities of false positive and false negative re- 
sults for various screening criteria based on LDH lev- 
els are shown in Tables V and VI. Here, a “false posi- 
tive” occurs if the screening rule does not predict 
anemia for a patient who later has anemia. The rates 
in Tables V and VI were estimated by applying the 
indicated rule to data in patients in the specified 
TABLE V 
Estimated Error Rates (%) for Predicting Anemia on the 
Basis of LDH Level of 250 Units 
False False 
Postoperative Year Positives (%) Negatives (%) 
l(16, 20) 25 19* 
2 (19, 18) 28 5* 
3 (12. 11) 27 17’ 
4 (11, 5) 20 9 
* False negatives determined at least lyear before diagnosis. 
Figures in parentheses indicate number of anemic patients 
(first figure)and number of nonanemic patients.(second figure). 
TABLE VI 
Estimated Error Rates in Percent Based on Last Preanemic, 
LDH Reading for Various Screening Rules for 11 Anemic and 
40 Nonanemic Patients 
Rule: Predict Anemia False False 
If LDH Greater Than (units) Positives (%) Negatives (%) 
150 68 4 
200 39 4 
225 31 4 
250 28 4 
275 17 7 
300 13 10 
TABLE VII 
Number of Diagnoses of Anemia by PostoperativeYear 
and Valve Series 
Year 
Valve Series 1 2 3 4 5 
2300 9 (7) 2 (18) 3 (16) 3 (16) 1 
2310-2320 9 (29) l(l9) l(7) . . . . . . 
Figures in parentheses indicate number of patients studied 
in our clinic for that postoperative year. The number of patients 
with valve 2300 studied in postoperative year 1 is less than the 
number of diagnoses because this time interval antedated our 
routine screening program. 
postoperative years, then observing the proportions 
of patients misclassified at the end of the study peri- 
od. Table V gives the estimated error rate for the rule 
that predicts anemia for patients with an LDH value 
exceeding 250 units. This rule will result in about 25 
percent false positive and 5 to 18 percent false nega- 
tive readings. All values that would have been false 
negative by this rule were obtained at least 1 year be- 
fore the diagnosis of the anemia. Consequently, bet- 
ter estimates of the error rates might be obtained by 
considering only the latest LDH values for each pa- 
tient. Estimated error rates for various screening 
rules based on the latest measurement are presented 
in Table VI. Using 250 units as the value to predict 
anemia would have resulted in 28 percent false posi- 
tive and 4 percent false negative readings. The esti- 
mate of the false positive rate may be somewhat high, 
since anemia may still develop in some of these pa- 
tients. 
Comparison of 2300 and 2310-2320 valve series: 
Table VII gives the number of, diagnoses of anemia 
by postoperative year and valve series. It is impor- 
tant to note that the mean follow-up period is ap- 
proximately 4 years for the 2300 series and about 2 
years for the 2310 and 2320 series. In the first postop- 
erative year the number of patients studied in the 
2300 series is smaller than the number of diagnoses of 
anemia because these diagnoses antedated our rou- 
tine screening program. The presence of “definite” 
paravalvular leakage accelerated the onset of hemoly- 
sis, giving a mean onset time of 15 months in 10 pa- 
tients as compared with 20 months in 18 patients 
without “definite” paravalvular leakage. 
Discussion 
Hemolysis and valve cloth wear: Iron depletion 
through urinary loss has been the usual explanation 
for anemia of late onset secondary to prosthetic valve 
hemolysis. We believe that our data indicate that in- 
creasing hemolysis is an additional factor in the late 
onset of anemia in patients with the cloth-covered 
aortic valve prosthesis. Increased rates of hemolysis 
may be evident during an anemic crisis; however, the 
majority of our patients had increasing LDH values 
in spite of a stable hematocrit. We believe that cloth 
wear is an important factor in the increasing hemoly- 
sis. We performed reoperations in six patients be- 
cause of severe hemolysis, and only one had no evi- 
dence of cloth wear. Valve wear with increasingly se- 
vere hemolysis has been reported previously.7 
Identifying patients at risk for anemia: Our 
data suggest that patients at increased risk of anemia 
can be identified. The postoperative hematocrit 
value is commonly lower than the preoperative value, 
but it may stabilize at this lower level until the onset 
of anemia several years later. This onset may be pre- 
cipitous and iron depletion certainly is an important 
factor in this event. The reticulocyte level is com- 
monly in excess of 2.5 percent in patients at risk of 
having anemia within the coming year. We do not 
have data for the predictive value of the preanemia 
536 October 3, 1974 The American Journal of CARDIOLOGY Volume 34 
HEMOLYSIS AND AORTIC VALVE PROSTHESIS-SANTINGA ET AL. 
serum hemoglobin levels. However, a value in excess 
of 40 mg/lOO ml was common in those patients with 
anemia, whereas only 3 of 17 patients without a pres- 
ent diagnosis of anemia had values greater than 40 
mg/lOO ml. 
The serum LDH level is perhaps the most useful 
screening test available. If the patient’s serum LDH 
activity is 400 units or greater, anemia is likely to de- 
velop or may already be present. Only 4 of 42 pa- 
tients in the nonanemic group had values in this 
range. The future of these latter patients is, of course, 
still uncertain. An LDH activity of 250 units would 
identify a population at increased risk of anemia. A 
preanemia LDH level of 250 units in our study gave a 
28 percent false positive, but only a 4 percent false 
negative result, which is acceptable for a screening 
test. 
There is considerable variance in the manner of es- 
timation for LDH activity in serum by laboratories. 
Variables such as direction of the enzymatic reaction, 
temperature (ranging from 37’ C to 25” C) and end- 
point vs. kinetic assays make interhospital transfer of 
units of LDH activity nearly impossible.8 Because 
there is no satisfactory correction factor to standard- 
ize the unit of activity, the data presented here, par- 
ticularly those relating to the serum LDH activity 
levels that indicate the patient is at risk, can be con- 
verted to use in other clinical settings by the fol- 
lowing steps: (1) establish “normal” range of activity 
for the individual laboratory’s technique of assay, 
and (2) multiply the upper limit of normal activity by 
4. This method of expression avoids confusion over 
units and expresses abnormal activity in terms of 
“times normal.” In the technique used in t.his report 
the critical activity level of 250 units is four times the 
established upper limit of normal for that assay and 
would correspond to 1,600 units as estimated by the 
LDH technique of Henry et al.” 
Other methods for detecting the severity of hemol- 
ysis have been reported. The plasma hemopexin level 
was reported by Eyster et al. lo as being a good indica- 
tor of severe hemolysis. Patients with a high level of 
hemosiderin in urinary sediment were found to have 
marked hemolysis. l l However, the predictive ability 
of these findings has not been demonstrated, and the 
limited availability of these studies restricts their 
use. Since the LDH level correlated well with the de- 
gree of hemolysis and is easily available, we believe it 
offers the best present screening test for hemolysis. 
Clinical implications: Routine monitoring of 
LDH levels in all patients with a cloth-covered aortic 
prosthesis should be carried out. A sudden rise in 
LDH activity of over 70 units should alert the physi- 
cian to the possibility of cloth wear and risk of ane- 
mia. Values exceeding 250 units of LDH would place 
the patient in a high risk category. We believe that 
these patients should be followed up closely for the 
onset of anemia. 
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